The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-methyl 4-(5-chloro-2-(1-(3-(3-chlorobenzyl)ureido)-2-phenylethyl)-1H-imidazol-4-yl)phenylcarbamate ID: ALA4535183
PubChem CID: 57976362
Max Phase: Preclinical
Molecular Formula: C27H25Cl2N5O3
Molecular Weight: 538.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)Nc1ccc(-c2nc([C@H](Cc3ccccc3)NC(=O)NCc3cccc(Cl)c3)[nH]c2Cl)cc1
Standard InChI: InChI=1S/C27H25Cl2N5O3/c1-37-27(36)31-21-12-10-19(11-13-21)23-24(29)34-25(33-23)22(15-17-6-3-2-4-7-17)32-26(35)30-16-18-8-5-9-20(28)14-18/h2-14,22H,15-16H2,1H3,(H,31,36)(H,33,34)(H2,30,32,35)/t22-/m0/s1
Standard InChI Key: NGJNOWFFVAKFDQ-QFIPXVFZSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
8.2922 -3.6202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1360 -4.2980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0026 -2.3828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8439 -5.0014 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0023 -5.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7219 -4.8673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0011 -6.1138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1473 -4.0410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5426 -3.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3615 -3.5839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0188 -5.0047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5794 -4.0369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9944 -1.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0072 -4.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0991 -4.8495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7135 -2.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4280 -1.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6014 -4.2924 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2418 -5.7678 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.4439 -6.1133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6113 -5.7245 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8577 -2.7992 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9065 -5.0154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7763 -4.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8600 -3.6243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7625 -3.6857 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2613 -5.7178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3690 -5.0079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4409 -5.2786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3150 -4.3003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1496 -4.8661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7235 -7.3538 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.2898 -2.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7237 -6.5287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7038 -1.1447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5487 -5.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4300 -2.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34 32 1 0
23 30 2 0
18 11 1 0
24 10 1 0
26 14 2 0
30 26 1 0
20 29 1 0
25 12 1 0
8 25 1 0
36 28 1 0
13 3 1 0
25 22 2 0
9 2 1 0
35 13 2 0
29 31 1 0
6 5 1 0
14 15 1 0
37 17 2 0
15 23 1 0
11 21 2 0
28 24 2 0
31 8 1 0
33 3 1 0
7 34 1 0
4 27 1 0
1 14 1 0
11 4 1 0
10 9 2 0
29 6 2 0
5 7 2 0
12 1 1 0
17 35 1 0
34 20 2 0
3 16 2 0
16 37 1 0
23 19 1 0
24 18 1 0
1 33 1 1
2 36 2 0
30 2 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 538.44Molecular Weight (Monoisotopic): 537.1334AlogP: 6.35#Rotatable Bonds: 8Polar Surface Area: 108.14Molecular Species: NEUTRALHBA: 4HBD: 4#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.23CX Basic pKa: 3.92CX LogP: 5.53CX LogD: 5.52Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.21Np Likeness Score: -1.37
References 1. Clark CG, Rossi KA, Corte JR, Fang T, Smallheer JM, De Lucca I, Nirschl DS, Orwat MJ, Pinto DJP, Hu Z, Wang Y, Yang W, Jeon Y, Ewing WR, Myers JE, Sheriff S, Lou Z, Bozarth JM, Wu Y, Rendina A, Harper T, Zheng J, Xin B, Xiang Q, Luettgen JM, Seiffert DA, Wexler RR, Lam PYS.. (2019) Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability., 29 (19): [PMID:31445854 ] [10.1016/j.bmcl.2019.08.008 ]